Vitalibis Debt / Equity
Cos'è Debt / Equity di Vitalibis?
Debt / Equity di Vitalibis, Inc. è -1.43
Qual è la definizione di Debt / Equity?
Il rapporto debito è un rapporto finanziario che indica la proporzione relativa del patrimonio netto e del debito utilizzato per finanziare le attività di una società.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt / Equity di aziende nel Health Care settore su OTC rispetto a Vitalibis
Cosa fa Vitalibis?
Vitalibis, Inc. operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products. The company markets and sells consumer products under the Vitalibis brand. It also sells water soluble phytocannabinoid rich hemp powder. The company was formerly known as Sheng Ying Entertainment Corp. and changed its name to Vitalibis, Inc. in February 2018. Vitalibis, Inc. was founded in 2014 and is based in Las Vegas, Nevada. On June 15, 2020, Vitalibis, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.
Aziende con debt / equity simili a Vitalibis
- Stagezero Life Sciences Ltd ha Debt / Equity di -1.44
- Dragon King ha Debt / Equity di -1.44
- Pathfinder Minerals Plc ha Debt / Equity di -1.44
- U.S. Lithium ha Debt / Equity di -1.43
- GINSMS ha Debt / Equity di -1.43
- Galectin Therapeutics Inc ha Debt / Equity di -1.43
- Vitalibis ha Debt / Equity di -1.43
- Landcadia II ha Debt / Equity di -1.42
- Norwood Systems ha Debt / Equity di -1.42
- Omkar Speciality Chemicals ha Debt / Equity di -1.42
- iSIGN Media Solutions ha Debt / Equity di -1.42
- Ecoark ha Debt / Equity di -1.42
- Orege Societe Anonyme ha Debt / Equity di -1.42